1. Home
  2. GBIO vs KTCC Comparison

GBIO vs KTCC Comparison

Compare GBIO & KTCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • KTCC
  • Stock Information
  • Founded
  • GBIO 2016
  • KTCC 1969
  • Country
  • GBIO United States
  • KTCC United States
  • Employees
  • GBIO N/A
  • KTCC N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • KTCC Electrical Products
  • Sector
  • GBIO Health Care
  • KTCC Technology
  • Exchange
  • GBIO Nasdaq
  • KTCC Nasdaq
  • Market Cap
  • GBIO 29.5M
  • KTCC 31.2M
  • IPO Year
  • GBIO 2020
  • KTCC N/A
  • Fundamental
  • Price
  • GBIO $5.99
  • KTCC $3.59
  • Analyst Decision
  • GBIO Buy
  • KTCC
  • Analyst Count
  • GBIO 4
  • KTCC 0
  • Target Price
  • GBIO $10.67
  • KTCC N/A
  • AVG Volume (30 Days)
  • GBIO 70.7K
  • KTCC 34.6K
  • Earning Date
  • GBIO 11-05-2025
  • KTCC 11-04-2025
  • Dividend Yield
  • GBIO N/A
  • KTCC N/A
  • EPS Growth
  • GBIO N/A
  • KTCC N/A
  • EPS
  • GBIO N/A
  • KTCC N/A
  • Revenue
  • GBIO $21,230,000.00
  • KTCC $467,871,000.00
  • Revenue This Year
  • GBIO N/A
  • KTCC N/A
  • Revenue Next Year
  • GBIO N/A
  • KTCC N/A
  • P/E Ratio
  • GBIO N/A
  • KTCC N/A
  • Revenue Growth
  • GBIO 61.15
  • KTCC N/A
  • 52 Week Low
  • GBIO $3.00
  • KTCC $2.21
  • 52 Week High
  • GBIO $29.10
  • KTCC $6.14
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 54.23
  • KTCC 67.49
  • Support Level
  • GBIO $5.51
  • KTCC $3.36
  • Resistance Level
  • GBIO $6.04
  • KTCC $3.70
  • Average True Range (ATR)
  • GBIO 0.32
  • KTCC 0.18
  • MACD
  • GBIO -0.08
  • KTCC 0.05
  • Stochastic Oscillator
  • GBIO 64.86
  • KTCC 87.36

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About KTCC Key Tronic Corporation

Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.

Share on Social Networks: